60 Degrees Pharmaceutical... (SXTP)
0.91
0.01 (1.00%)
At close: Jan 15, 2025, 3:59 PM
0.95
4.97%
After-hours Jan 15, 2025, 04:02 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -3.77M | -6.18M | -4.26M | -3.05M |
| Depreciation & Amortization | 100.37K | 78.79K | 71.78K | 27.86K |
| Stock-Based Compensation | n/a | n/a | n/a | n/a |
| Other Working Capital | 407.35K | 3.09M | 2.72M | 2.10M |
| Other Non-Cash Items | -1.28M | 1.78M | 642.92K | 425.74K |
| Deferred Income Tax | n/a | n/a | n/a | n/a |
| Change in Working Capital | 405.36K | 3.31M | 2.90M | 2.43M |
| Operating Cash Flow | -4.54M | -1.01M | -649.11K | -167.30K |
| Capital Expenditures | -115.89K | -60.13K | -35.39K | -70.98K |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -58.27K | -60.13K | -32.32K | -70.98K |
| Investing Cash Flow | -115.89K | -60.13K | -35.39K | -70.98K |
| Debt Repayment | -961.11K | 1.10M | 611.23K | 277.36K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 981.35K | 116.71K | n/a | n/a |
| Financial Cash Flow | 6.47M | 1.22M | 611.23K | 277.36K |
| Net Cash Flow | 1.88M | 149.47K | -76.30K | -95.17K |
| Free Cash Flow | -4.66M | -1.07M | -684.50K | -238.28K |